Literature DB >> 9430315

Positron emission tomography in children with neurofibromatosis-1.

A M Kaplan1, K Chen, M A Lawson, D L Wodrich, C T Bonstelle, E M Reiman.   

Abstract

Neurofibromatosis-1 is an autosomal dominant genetic disorder commonly associated with neuropsychological complications. Focal areas of high signal intensity on magnetic resonance imaging (MRI) scans occur commonly but have shown inconsistent correlation with neuropsychological problems. Positron emission tomography (PET) scans utilizing [18F]fluoro-2-deoxy-D-glucose and MRI studies were performed on 10 children with neurofibromatosis-1 and multiple focal areas of high signal intensity to evaluate the regional cerebral metabolic rate for glucose of these lesions and other central nervous system structures. Co-registered PET and MRI studies confirmed reduced glucose metabolism of large focal areas of high signal intensity. Visual inspection and semiquantitative analysis of PET images demonstrated thalamic hypometabolism and varying degrees of cortical inhomogeneity in all cases of neurofibromatosis-1 compared to normal controls. Although a primary defect of the thalamus or cerebral cortex has not been defined, the metabolic abnormalities of this study suggest a potential relationship between these structures and the neuropsychological dysfunctions noted in neurofibromatosis-1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9430315     DOI: 10.1177/088307389701200807

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  12 in total

1.  Has PET become an important clinical tool in paediatric imaging?

Authors:  Klaus Hahn; Thomas Pfluger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-05       Impact factor: 9.236

2.  Utility of positron emission tomography for tumour surveillance in children with neurofibromatosis type 1.

Authors:  Mahendranath Moharir; Kevin London; Robert Howman-Giles; Kathryn North
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-24       Impact factor: 9.236

3.  Perfusion single photon emission computed tomography in a mouse model of neurofibromatosis type 1: towards a biomarker of neurologic deficits.

Authors:  Ivayla Apostolova; Dagmara Niedzielska; Thorsten Derlin; Eva J Koziolek; Holger Amthauer; Benedikt Salmen; Jens Pahnke; Winfried Brenner; Victor F Mautner; Ralph Buchert
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-18       Impact factor: 6.200

4.  Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities.

Authors:  R G Steen; J S Taylor; J W Langston; J O Glass; V R Brewer; W E Reddick; R Mages; E K Pivnick
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

5.  T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning.

Authors:  Shelley L Hyman; Deepak S Gill; Edwin Arthur Shores; Adam Steinberg; Kathryn N North
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02-13       Impact factor: 10.154

6.  Multivariate pattern analysis reveals subtle brain anomalies relevant to the cognitive phenotype in neurofibromatosis type 1.

Authors:  João V Duarte; Maria J Ribeiro; Inês R Violante; Gil Cunha; Eduardo Silva; Miguel Castelo-Branco
Journal:  Hum Brain Mapp       Date:  2012-09-11       Impact factor: 5.038

7.  Reduced cerebral arterial spin-labeled perfusion in children with neurofibromatosis type 1.

Authors:  K W Yeom; R M Lober; P D Barnes; C J Campen
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-13       Impact factor: 3.825

8.  GABA deficiency in NF1: A multimodal [11C]-flumazenil and spectroscopy study.

Authors:  Inês R Violante; Miguel Patricio; Inês Bernardino; José Rebola; Antero J Abrunhosa; Nuno Ferreira; Miguel Castelo-Branco
Journal:  Neurology       Date:  2016-07-29       Impact factor: 9.910

Review 9.  Skeletal muscle and motor deficits in Neurofibromatosis Type 1.

Authors:  M A Summers; K G Quinlan; J M Payne; D G Little; K N North; A Schindeler
Journal:  J Musculoskelet Neuronal Interact       Date:  2015-06       Impact factor: 2.041

10.  Gyrification, cortical and subcortical morphometry in neurofibromatosis type 1: an uneven profile of developmental abnormalities.

Authors:  Inês R Violante; Maria J Ribeiro; Eduardo D Silva; Miguel Castelo-Branco
Journal:  J Neurodev Disord       Date:  2013-02-13       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.